The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Balloon Valvuloplasty Device Market Projected To Reach By 2030?
The market for balloon valvuloplasty devices has experienced significant growth over recent years. This market is projected to expand from $2.57 billion in 2025 to $2.73 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.9%. Historical growth can be ascribed to several factors, including an increase in the prevalence of cardiac valve stenosis, the early adoption of minimally invasive interventional cardiology procedures, advancements in standard and compliant balloon technologies, the expansion of hospital-based cardiac catheterization laboratories, and rising treatment volumes for pediatric congenital heart conditions.
The balloon valvuloplasty device market size is projected to experience robust growth in the upcoming years, with expectations to reach $3.35 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.3%. This anticipated expansion during the forecast period can be attributed to a growing aging population suffering from aortic and mitral valve stenosis, an escalating demand for high-pressure and scoring balloon devices, the wider application of balloon valvuloplasty in ambulatory and specialty clinics, an increasing move towards non-surgical cardiac treatment pathways, and continuous innovation in balloon materials and device design. Key trends in the forecast period include a heightened preference for minimally invasive valve repair procedures, the rising adoption of balloon valvuloplasty as an alternative to open-heart surgery, its growing utilization in pediatric and adult congenital heart valve disorders, the expansion of valve dilation procedures within specialty cardiology centers, and a focused effort on improving patient outcomes and achieving shorter recovery times.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17090&type=smp
Which Important Drivers Are Guiding The Balloon Valvuloplasty Device Market Growth?
The increasing preference for minimally invasive surgical techniques is anticipated to fuel the expansion of the balloon valvuloplasty device market in the future. These procedures are defined as medical interventions carried out through small incisions or natural bodily orifices, leading to less tissue damage and quicker healing times when contrasted with conventional operations. There is a growing need for minimally invasive methods because they offer quicker recuperation, a reduced chance of adverse events, and less pain after surgery compared to traditional approaches. Within minimally invasive surgeries, balloon valvuloplasty devices are employed to expand constricted heart valves, enhancing blood circulation and alleviating symptoms. For example, in January 2024, Intuitive Surgical Inc., a US-based robotic product manufacturer, announced the deployment of 415 da Vinci surgical systems—robotic platforms designed for minimally invasive surgery—in the fourth quarter of 2023. This figure represented a 12% increase over 2022. Consequently, the rising inclination towards minimally invasive procedures is propelling the expansion of the balloon valvuloplasty device market.
What Are The Different Segment Types In The Balloon Valvuloplasty Device Market Segment Breakdown?
The balloon valvuloplasty device market covered in this report is segmented –
1) By Product Type: Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon
2) By Age Group: Pediatric, Adult
3) By End-use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
Subsegments:
1) By Standard Balloon: Non-Compliant Balloons, Compliant Balloons
2) By Cutting Balloon: Single-Cutting Balloon, Multi-Cutting Balloon
3) By Scoring Balloon: Single-Score Balloons, Dual-Score Balloons
4) By High-Pressure Balloon: Non-Compliant High-Pressure Balloons, Compliant High-Pressure Balloons
5) By Low-Pressure Balloon: Semi-Compliant Low-Pressure Balloons, Non-Compliant Low-Pressure Balloons
What Trends Are Influencing The Evolution Of The Balloon Valvuloplasty Device Market?
Leading companies in the balloon valvuloplasty device market are prioritizing the development of advanced products, such as Pacing Guidewires, to gain a competitive advantage. A pacing guidewire is a specialized wire utilized to provide temporary cardiac pacing throughout a procedure, ensuring the heart maintains a steady rhythm while the balloon catheter is inserted and inflated to dilate the narrowed valve. For instance, in June 2023, Teleflex Incorporated, a US-based medical device company, secured clearance from the Food and Drug Administration (FDA) for the Wattson Temporary Pacing Guidewire. This novel device is specifically intended for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) procedures. The Wattson Temporary Pacing Guidewire features dual functionality, supporting both valve delivery and ventricular bipolar pacing during these structural heart interventions. Its flexible distal pigtail shape, multiple electrodes, and bipolar design are engineered to help mitigate the risk of ventricular perforation while ensuring reliable electrical capture during rapid pacing.
Who Are The Well-Known Companies In The Balloon Valvuloplasty Device Market?
Major companies operating in the balloon valvuloplasty device market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Edwards Lifesciences Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical Incorporated, Balton Sp z o o, Meril Life Sciences Pvt Ltd, JenaValve Technology Inc, Osypka Medical GmbH, Scitech Medical, Translumina GmbH, AndraTec GmbH, Palex Medical SA, Biosensors International Group Ltd, Hexacath, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, QT Vascular Ltd
Get The Full Balloon Valvuloplasty Device Market Report:
https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report
Which Region Leads The Balloon Valvuloplasty Device Market In Overall Market Size?
North America was the largest region in the balloon valvuloplasty device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Balloon Valvuloplasty Device Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=17090&type=smp
Browse Through More Reports Similar to the Global Balloon Valvuloplasty Device Market 2026, By The Business Research Company
Angioplasty Balloons Market Report 2026
https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report
Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Pta Balloon Catheter Market Report 2026
https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model